Senestech (NASDAQ:SNES) Major Shareholder Glenbrook Capital Management Acquires 19,725 Shares

Senestech, Inc. (NASDAQ:SNES) major shareholder Glenbrook Capital Management acquired 19,725 shares of the firm’s stock in a transaction that occurred on Tuesday, March 17th. The shares were bought at an average cost of $1.79 per share, with a total value of $35,307.75. Following the completion of the purchase, the insider owned 890,635 shares of the company’s stock, valued at $1,594,236.65. This trade represents a 2.26% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Major shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Glenbrook Capital Management also recently made the following trade(s):

• On Monday, March 16th, Glenbrook Capital Management acquired 5,060 shares of Senestech stock. The shares were purchased at an average price of $1.86 per share, with a total value of $9,411.60.
• On Friday, March 13th, Glenbrook Capital Management purchased 146,249 shares of Senestech stock. The stock was purchased at an average cost of $1.95 per share, with a total value of $285,185.55.
• On Thursday, February 19th, Glenbrook Capital Management bought 34,613 shares of Senestech stock. The stock was acquired at an average cost of $2.40 per share, with a total value of $83,071.20.
• On Wednesday, February 18th, Glenbrook Capital Management acquired 10,481 shares of Senestech stock. The stock was acquired at an average price of $2.29 per share, with a total value of $24,001.49.
• On Tuesday, February 17th, Glenbrook Capital Management purchased 40,807 shares of Senestech stock. The stock was bought at an average price of $2.29 per share, with a total value of $93,448.03.
• On Friday, February 13th, Glenbrook Capital Management bought 15,390 shares of Senestech stock. The shares were purchased at an average price of $1.89 per share, with a total value of $29,087.10.
• On Thursday, February 12th, Glenbrook Capital Management purchased 7,956 shares of Senestech stock. The stock was purchased at an average price of $1.72 per share, for a total transaction of $13,684.32.
• On Wednesday, February 11th, Glenbrook Capital Management acquired 8,000 shares of Senestech stock. The shares were purchased at an average cost of $1.73 per share, with a total value of $13,840.00.
• On Thursday, February 5th, Glenbrook Capital Management acquired 2,884 shares of Senestech stock. The shares were purchased at an average price of $1.77 per share, with a total value of $5,104.68.
• On Wednesday, February 4th, Glenbrook Capital Management bought 5,685 shares of Senestech stock. The stock was purchased at an average cost of $1.82 per share, for a total transaction of $10,346.70.

Senestech Stock Down 4.8%

NASDAQ SNES traded down $0.09 during trading on Tuesday, hitting $1.77. The stock had a trading volume of 77,169 shares, compared to its average volume of 69,003. Senestech, Inc. has a 12 month low of $1.30 and a 12 month high of $6.24. The company has a debt-to-equity ratio of 0.02, a quick ratio of 14.73 and a current ratio of 12.61. The company’s 50-day moving average price is $2.06 and its two-hundred day moving average price is $2.97. The company has a market capitalization of $9.38 million, a PE ratio of -0.64 and a beta of 0.15.

Senestech (NASDAQ:SNES) last issued its quarterly earnings results on Thursday, March 12th. The company reported ($0.29) earnings per share for the quarter, topping the consensus estimate of ($0.30) by $0.01. Senestech had a negative net margin of 287.39% and a negative return on equity of 78.74%. The company had revenue of $0.42 million during the quarter, compared to analysts’ expectations of $0.78 million. As a group, sell-side analysts forecast that Senestech, Inc. will post -10.22 EPS for the current year.

Analyst Ratings Changes

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Senestech in a research report on Monday, December 29th. One analyst has rated the stock with a Strong Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold”.

Institutional Trading of Senestech

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Sabby Management LLC boosted its position in Senestech by 195.4% during the fourth quarter. Sabby Management LLC now owns 210,564 shares of the company’s stock valued at $451,000 after purchasing an additional 139,281 shares during the last quarter. DRW Securities LLC increased its position in shares of Senestech by 171.1% during the 4th quarter. DRW Securities LLC now owns 82,107 shares of the company’s stock worth $176,000 after purchasing an additional 51,818 shares during the last quarter. Corsair Capital Management L.P. bought a new stake in shares of Senestech during the 2nd quarter worth approximately $255,000. Renaissance Technologies LLC raised its stake in shares of Senestech by 35.2% during the 4th quarter. Renaissance Technologies LLC now owns 142,800 shares of the company’s stock worth $306,000 after purchasing an additional 37,165 shares in the last quarter. Finally, Jane Street Group LLC acquired a new stake in shares of Senestech in the 2nd quarter valued at approximately $161,000. Institutional investors own 5.19% of the company’s stock.

Senestech Company Profile

SenesTech, Inc (NASDAQ: SNES) is a biotechnology company specializing in non-lethal pest management solutions. The company’s core focus is the development and commercialization of fertility-based control methods for commensal rodents, providing an alternative to traditional rodenticides. By targeting the reproductive cycle of rats, SenesTech aims to reduce rodent populations over time without the use of toxic chemicals, offering a more sustainable approach for pest management professionals.

The company’s flagship product, ContraPest®, is an EPA-registered liquid bait that disrupts rodent reproduction.